Trademark: 90252029
Word
FILIDITY
Status
Dead
Status Code
605
Status Date
Wednesday, March 30, 2022
Serial Number
90252029
Mark Type
4000
Filing Date
Tuesday, October 13, 2020
Published for Opposition
Tuesday, April 6, 2021
Abandoned Date
Tuesday, March 29, 2022

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Trademark Events
Mar 30, 2022
Abandonment Notice E-Mailed - After Publication
Mar 30, 2022
Abandonment - After Publication
Mar 29, 2022
Teas Express Abandonment Received
Oct 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 21, 2021
Extension 1 Granted
Oct 21, 2021
Extension 1 Filed
Oct 21, 2021
Teas Extension Received
Jun 1, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2021
Published For Opposition
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Mar 1, 2021
Approved For Pub - Principal Register
Feb 26, 2021
Assigned To Examiner
Nov 30, 2020
New Application Office Supplied Data Entered In Tram
Oct 16, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24